Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Mr Duncan Chui

28 Sep 2012 18:27

RNS Number : 5264N
China Private Equity Inv Hldgs Ld
28 September 2012
 



 

28 September 2012

 

 

 

China Private Equity Investment Holdings Limited (AIM: CPEH)

 

("CPE" or the "Company")

 

Mr Duncan Chui

 

Further to the announcement of 28 August 2012, China Private Equity Investments Holdings Limited (AIM: CPEH) announces the following further information regarding Mr Duncan Chui, the Company's Chief Investment Officer (who is not a director of the Company), in relation to the censure of him by the Market Misconduct Tribunal in Hong Kong ("MMT") (the "Censure"),

 

The Censure relates to dealings by Mr Chui in the shares of a Hong Kong Stock Exchange listed company, Sino Katalytics Investment Corporation ("SKIC") which is unrelated to the Company, and which were undertaken in January 2009, prior to CPE being admitted to trading on AIM in October 2009. The report of the MMT concluded that Mr Chui was culpable of false trading, price rigging and stock market manipulation. As a result, the MMT has ordered that Mr Chui should not act as a director or take part in the management of a listed company for a period of two years, which Mr Chui has been advised relates to Hong Kong listed companies. Further, Mr Chui is not permitted, directly or indirectly, to deal in securities in Hong Kong and he has been ordered to pay aggregate costs to the Government of Hong Kong and the Hong Kong Securities and Futures Commission of HK$1.3 million.

 

The board of directors of the Company (the "Board") reiterates that the day to day management of the Company has not changed and there is no impact on the portfolio of CPE's investments as a result of the MMT decision. Specifically, the proposed listing of Fortel BVI continues to progress, with the listing application anticipated to be submitted to the Hong Kong Stock Exchange by the end of this year, as set out in the Company's interim results for the six months to 30 June 2012, announced on 26 September 2012. Mr Chui is not a director of any of CPE's investee companies and he does not participate in the day to day management of these companies.

 

Mr Chui has strongly denied the allegations made against him and has launched an appeal against the decisions of the MMT.

 

The MMT reports can be found on the MMT website at www.mmt.gov.hk.

 

For further information, please visit www.cpe-invest.comor contact:

 

Maria Leung, China Private Equity Investment Holdings Ltd:

 

Azhic Basirov / Siobhan Sergeant,

Smith & Williamson Corporate Finance Ltd:

 

Allan Piper, First City Public Relations (Hong Kong):

 

Simon Hudson, Tavistock Communications (London):

 

www.cpe-invest.com

 

+852 2801 6770

 

 

+44 (0) 20 7131 4000

 

+852 2854 2666

 

+44 (0) 20 7920 3170

 

Ticker symbol: CPEH

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSELFWAFESEEU
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.